Genes & Diseases Open Access Editors-in-Chief: Ailong Huang, Tong-Chuan He
Keyword: PD-L1
Full Length Article | Open Access
The role of distinct co-mutation patterns with TP53 mutation in immunotherapy for NSCLC
Published: 09 April 2020
2022, 9 (1): 245-251
Review Article | Open Access
Paradox-driven adventures in the development of cancer immunology and immunotherapy
Published: 10 July 2019
2019, 6 (3): 224-231
Review Article | Open Access
Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies
Published: 03 July 2019
2019, 6 (3): 232-246
Review Article | Open Access
Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
Published: 18 February 2022
2023, 10 (3): 848-863
Full Length Article | Open Access
PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain
Published: 08 December 2022
2023, 10 (4): 1702-1713
Total 5